Clinical Trials Browser

Phase 1 × 2'-((4'-trifluoromethanesulfonyloxy)phenyl)-N-methanesulfonylpropionamide × 1 year × Clear all

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation